Avalo Therapeutics, Inc. (AVTX) Earnings
NASDAQ·Healthcare·Biotechnology
$15.34
+6.91%
Mkt Cap $147.95M
EPS — Estimate vs Actual
Mkt Cap
$147.95M
P/E
—
Fwd P/E
—
P/S
2507.68
Rev TTM
—
EPS TTM
-$5.83
NASDAQ·Healthcare·Biotechnology
$15.34
+6.91%
Mkt Cap $147.95M
Mkt Cap
$147.95M
P/E
—
Fwd P/E
—
P/S
2507.68
Rev TTM
—
EPS TTM
-$5.83